Possibly, venetoclax sensitivity arises through NPM1-mutation-driven HOX gene expression, since HOX gene expression was shown to be associated with high sensitivity to BCL-2 inhibition in AML cells [65]. Here, NPM1 is linked to acute myeloid leukemia.